BioIMeD
BioIMeD is an academic spin-off from the University of Trieste developing AI-based solutions for diagnosing, treating, and monitoring serious diseases. Their primary goal is to anticipate disease manifestation through primary screening tools and predictive analysis. Their key product is BiopIA, a device that automates liquid biopsy by integrating microfluidics, precision sensors, and AI software, aiming to significantly reduce analysis time and improve cell recovery. They also offer DomotIA, an IoT-based remote patient monitoring system for healthcare providers and patients, enhancing continuous care and operational efficiency. The company focuses on innovation in medical devices with a strong emphasis on AI and microfluidics.
BioIMeD
BioIMeD is an academic spin-off from the University of Trieste developing AI-based solutions for diagnosing, treating, and monitoring serious diseases. Their primary goal is to anticipate disease manifestation through primary screening tools and predictive analysis. Their key product is BiopIA, a device that automates liquid biopsy by integrating microfluidics, precision sensors, and AI software, aiming to significantly reduce analysis time and improve cell recovery. They also offer DomotIA, an IoT-based remote patient monitoring system for healthcare providers and patients, enhancing continuous care and operational efficiency. The company focuses on innovation in medical devices with a strong emphasis on AI and microfluidics.